Back to Search Start Over

Comparison of Toxicity and Efficacy Outcomes of Abiraterone and Enzalutamide in 198 Patients with Metastatic Castrate Resistant Prostate Cancer

Authors :
S. Walter
John McGrane
J. Palmer
A. Williams
T. Norris
Source :
Clinical Oncology. 29:e87-e88
Publication Year :
2017
Publisher :
Elsevier BV, 2017.

Subjects

Subjects :
Oncology
medicine.medical_specialty
business.industry
Castrate-resistant prostate cancer
03 medical and health sciences
Abiraterone
chemistry.chemical_compound
0302 clinical medicine
chemistry
030220 oncology & carcinogenesis
Internal medicine
Toxicity
medicine
Enzalutamide
Radiology, Nuclear Medicine and imaging
business
030215 immunology

Details

ISSN :
09366555
Volume :
29
Database :
OpenAIRE
Journal :
Clinical Oncology
Accession number :
edsair.doi...........4177122f115bced079cae19d1b3dcf33
Full Text :
https://doi.org/10.1016/j.clon.2016.11.020
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details